Loading...

APGE APOGEE THERAPEUTICS INC Product Launches 8-K Filing

PG T

PG

APOGEE THERAPEUTICS INC

(APGE)

2024 8-K

Earnings Announcement

Stock Offering Announcement

Product Expansion

Clinical Trials

Financial Results

Clinical Trial Update

Clinical Trial Launch

Financial Results

Clinical Trial Update

Clinical Trial Launch

Financial Results

Meeting Results

Appointment of Director

Earnings Report

Presentation of Phase 1 Data

Financial Results and Phase...

Financial Results Announcement

Appointment of Mark C. McKe...

External Links:

Apogee Therapeutics, Inc. has initiated dosing in its first clinical trial for APG808, a treatment for chronic obstructive pulmonary disease and other inflammatory diseases.

AI Assistant

APOGEE THERAPEUTICS INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.